NAFDAC Issues Public Alert For Combiart Dispersible Tablet 20/120mg
Sequel to the reported circulation of counterfeit Combiart Dispersible Tablet 20/120mg in the country, the National Agency for Food and Drugs Administration and Control (NAFDAC) has informed the public about potential health risks. Team@orientactualmags.com learned that NAFDAC disclosed this via a post on its